| Old Articles: <Older 44301-44310 Newer> |
 |
The Motley Fool September 23, 2010 Russ Krull |
10 Core Stocks for Your Portfolio: McDonald's McDonald's stock deserves to be on investors' menus.  |
The Motley Fool September 23, 2010 Esterhuizen & Sellitti |
8 Short Squeeze Candidates With Solid Financials These stocks have heavy short interest but seem to have solid financial strength.  |
The Motley Fool September 23, 2010 Sean Williams |
Peerless Manufacturing Is Looking Lofty Expenses are rising; profits are getting squeezed.  |
The Motley Fool September 23, 2010 Travis Hoium |
Has the King of Beers Abdicated? Budweiser has fallen so far it has to reintroduce itself by offering free beer.  |
The Motley Fool September 23, 2010 Brian Orelli |
A Blockbuster in Due Time Novartis' new multiple sclerosis drug, Gilenya, isn't king yet.  |
The Motley Fool September 23, 2010 Brian Orelli |
Ugly Side Effects Won't Derail This Drug Side effects don't matter much when there are no other treatment options, as in Cushing's disease.  |
The Motley Fool September 23, 2010 Anders Bylund |
Today's Superphone, Tomorrow's Toy The next generation of smartphones will make today's finest look like they came from Fisher-Price.  |
Registered Rep. September 23, 2010 Brad Zigler |
Gold, the Portfolio Hero of 2010 Some investors have had a golden touch this year. The fact that they touched gold, in fact, made them stand-out investors.  |
The Motley Fool September 23, 2010 Seth Jayson |
How Are the Margins at Syntel? Here's the current margin snapshot for Syntel and some of its sector and industry peers and direct competitors.  |
The Motley Fool September 23, 2010 Seth Jayson |
Will General Dynamics Bomb Next Quarter? Look here for a clue.  |
| <Older 44301-44310 Newer> Return to current articles. |